23.99
1.28%
-0.31
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DYN Giù?
Forum
Previsione
Dyne Therapeutics Inc Azioni (DYN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.17%
69.16
|
67.69 | 62.27 | 66.74 | 45.46 |
Operating Income/Loss |
2.17%
-69.16
|
-67.69 | -62.27 | -66.74 | -45.46 |
Income/Loss From Continuing Operations Before Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Income/Loss From Continuing Operations After Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Net Income/Loss
|
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
Diluted Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):